Prospective, multicentric, non-interventional study to assess the existing treatment of type 2 diabetes mellitus patients inadequately controlled with metformin monotherapy – KOMETA CZ
Authors:
Š. Svačina 1; V. Veselá 2
Authors place of work:
III. interní klinika 1. lékařské fakulty UK a VFN Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA
1; Novartis s. r. o., Praha, vedoucí pracovník MUDr. Richard Vonka
2
Published in the journal:
Vnitř Lék 2013; 59(12): 1043-1048
Category:
Original Contributions
Summary
After several years of diabetes, the first line anti-diabetic therapy of metformin usually starts failing. The KOMETA study was a prospective, multicentric, non-interventional epidemiological study in patients with type 2 diabetes mellitus inadequately controlled with metformin therapy. The study was conducted between 2010 and 2011. The study demonstrated a significant improvement in diabetes control, reduction of waist circumference, reduction in blood pressure and adjustment of dyslipidemia compared to baseline. Based on this study, our doctors select anti-diabetic drugs responsibly and they often use medicines without the hypoglycaemia risk. Nevertheless, more than two thirds of patients achieve the HbA1c control of under 6% according to IFCC. The main conclusion of this study is that under standard conditions it is possible to achieve full metabolic control of type 2 diabetic patients over the period of nine months.
Key words:
diabetes treatment – metformin failure – anti-diabetic drugs – dyslipidemia – hypertension
Zdroje
1. Inzucchi SE, Bergenstal RM, Buse JB et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012; 55: 1577–1596.
2. Svačina Š. Přístup zaměřený na pacienta – cesta k opravdové individualizaci léčby diabetu. Medicína po promoci 2012; 21: 93–95.
3. Karen I. Doporučený postup Diabetes mellitus. Praha: SVL ČLS JEP 2013.
4. Svačina Š. Doporučený postup pro léčbu diabetu u geriatrických pacientů. DMEV 2013.
5. Sattar N. Nový pohled na souvislosti mezi glykemií, diabetem a kardiovaskulární nemocí. Diabetologia (česká verze) 2013; 4: 19–21.
6. Škrha J et al. Diabetes mellitus – epidemiological study in Czech republic. DMEV 2005; 8: 5–12.
7. Doničová V, Tisoň P. Manažment pacientov s diabetes mellitus 2. typu s nedostatočnou glykemickou kompenzáciou na liečbe metformínom (výsledky prospektívnej, observačnej, multicentrickej neintervenčnej štúdie). Diabetes a obezita 2010; 11: 59–66.
8. Svačina Š. Léčba antidiabetiky a cévní onemocnění. Vnitř Lék 2010; 56: 313–316.
Štítky
Diabetology Endocrinology Internal medicineČlánok vyšiel v časopise
Internal Medicine
2013 Číslo 12
Najčítanejšie v tomto čísle
- Contemporary view on liver impairment in heart failure
- Histiocytic sarcoma
- Serious risk related to oral use of sodium phosphate solution
- Inflammatory borrelia – associated dilated cardiomyopathy